Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Behavioral and Brain Gene and Protein Changes in Female Mice Consuming Ethanol During Pregnancy and Lactation

  • Navarro, Daniela
  • Navarrete, Francisco
  • Villalba, Nerina
  • Torregrosa, Abraham B.
  • Caltana, Laura
  • Gasparyan, Ani
  • Brusco, Alicia
  • Manzanares, Jorge
Alcohol consumption during pregnancy and lactation remains a significant global issue. Preventive policies have proven insufficient, and consumption rates remain high, mainly due to a lack of awareness, the misconception that only high alcohol intake harms the fetus, inconsistent medical advice, and pre-existing alcohol use disorders. Alcohol consumption is linked to child harm during critical stages of development. Using a recently published model of fetal alcohol spectrum disorder (FASD) developed by our group, we analyzed brain changes in mothers who consumed alcohol during pregnancy and lactation and the behavioral consequences at the emotional-cognitive level and in caring for their offspring. We also considered the previous drinking history, using the paradigm of voluntary pre-gestational alcohol consumption. In addition, from gestational day 7 (GD7) until the day of sacrifice, mothers received a 3 g/kg dose of alcohol every 12 h via gavage. Our findings revealed deficiencies in maternal care, anxiety and depressive-like behavior, and aversive stimulus learning disturbances. These were associated with changes in gene targets linked to stress-axis regulation, reward circuits, and neuroplasticity. Additionally, we observed increased microgliosis and astrogliosis, indicating neuroinflammation in brain regions involved in cognition and emotional states' regulation., This work was supported by “Red de Investigación en Atención Primaria de Adicciones” (RD21/0009/0008), “Instituto de Salud Carlos III” (PI21/00488) and "Instituto de Investigación Biomédica y Sanitaria de Alicante" (ISABIAL) to J.M. The Instituto de Neurociencias “Centro de Excelencia Severo Ochoa" Grant CEX2021-001165-S funded by MCIN/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Predictive performance for alcohol use disorder of polygenic scores based on the general addiction risk factor and problematic alcohol use

  • Pérez Gutiérrez, Ana M.
  • Flórez, Gerardo
  • Blanco, Vanessa
  • Vázquez, Fernando L.
  • Abellí, Enric
  • Ortega, Lluisa
  • Serrano, Antonia
  • Arias, Francisco
  • Navarrete, Francisco
  • Fonseca, Francina
  • Estévez, Valentín
  • Gómez Trigo, Jesús
  • Facal, Fernando
  • Arrojo, Manuel
  • Manzanares, Jorge
  • Muga, Roberto
  • Miquel, Laia
  • Rodríguez de Fonseca, Fernando
  • Torrens, Marta
  • Rubio, Gabriel
  • Costas, Javier
[Background] Polygenic scores (PGSs) may play a role in targeted prevention of alcohol use disorder (AUD) by risk stratification. A latent genetic factor representing common liability to different substance use disorders (SUDs), known as the addiction risk factor (AdRF), was recently characterized. Our aim was to analyze the predictive performance for AUD of the AdRF PGS, comparing it with PGSs of problematic alcohol use (PAU) and of a common liability factor to substance use involvement., [Methods] PGSs were estimated across two datasets, comprising 1637 treatment-seeking AUD patients and 4178 controls. Logistic regression was used to evaluate performance of ancestry-normalized PGSs. Subgroup sensitivity analyses were tested based on clinical data. Sex-dependent effects were assessed by comparing PGSs between sexes., [Results] Tail-based measures revealed a better performance of the AdRF PGS than the other PGSs. Compared with the remaining subjects, those at the top decile of PGS presented a 3.3-fold greater odds of AUD. Other analyses revealed similar performance of the AdRF and PAU PGSs. The effect estimates were larger in subgroups with addictive and psychiatric comorbidities, higher severity, and earlier age of onset. Women patients presented higher PAU and AdRF PGSs than men patients., [Conclusions] This new generation of PGSs is one step closer to precision public health for AUD prevention. Alcohol-specific genetic factors are not determinant for predicting AUD risk, which may benefit from shared genetic susceptibility among different SUDs. Our data suggest sex differences in genetic susceptibility, probably as a result of complex interplay between genes and social environment., This work was supported by grants 2014I075 and 2022I058 from Plan Nacional sobre Drogas (Ministerio de Ciencia, Innovación y Universidades), from the Support Groups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); from Fondo de Investigación Sanitaria Instituto de Salud Carlos III (ISCIII) (PI22/00427; PI21/00488, PI16/00603 and PI20/00029); from Redes de Investigación Cooperativa Orientadas al Resultado en Salud (RICORS)-RIAPAD co-funded by ISCIII and the European Union (European Fund for Regional Development) (RD21/0009/0011, RD21/0009/0008, RD24/0003/0001, RD24/0003/0012 and RD24/0003/0016). The founders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publications., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effects of chronic ethanol consumption on brain GLP-1R gene expression in mice and humans

  • Torregrosa, Abraham B.
  • García-Gutiérrez, María Salud
  • Ortuño, Samanta
  • Manzanares, Jorge
The glucagon-like peptide-1 receptor (GLP-1R) has emerged as a promising therapeutic option for alcohol use disorder (AUD), yet the underlying mechanisms and neurocircuitry involved remain unclear. This study aimed to analyze GLP-1R gene expression changes in brain regions associated with alcohol's effects, including the prefrontal cortex (PFC), nucleus accumbens (NAc), and hippocampus (HIP), in mice following 42 days of voluntary ethanol consumption (VEC; 10% v/v) and postmortem samples from 18 patients with AUD. Additionally, we examined the expression of OPRM1 (mu-opioid receptor) and BDNF (brain-derived neurotrophic factor), key targets related to alcohol intake and reward, in the NAc and HIP, respectively. GLP-1R gene expression was significantly reduced in all brain regions of ethanol-exposed mice and AUD patients. These reductions paralleled decreased OPRM1 and BDNF expression in the NAc and HIP, respectively. Pearson and Spearman correlation analyses revealed no significant associations between gene expression and age, RIN, pH, postmortem interval (PMI), body mass index (BMI), smoking status, age of onset of alcohol use, or years of drinking. In summary, chronic alcohol consumption in humans or mice was associated with decreased GLP-1R gene expression in brain regions involved in the reinforcing effects of ethanol. These findings open new avenues for further research into how this emerging receptor could serve as a potential biomarker and therapeutic target in AUD., This work was supported by the INSTITUTO DE SALUD CARLOS III, SPANISH MINISTRY OF SCIENCE AND INNOVATION, grant number PI21/00488 to J.M. and RED DE INVESTIGACIÓN EN ATENCIÓN PRIMARIA DE ADICCIONES, INSTITUTO DE SALUD CARLOS III, SPANISH MINISTRY OF SCIENCE AND INNOVATION, grant number RD21/0009/0008 and RD24/0003/0002 to J.M., and Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa” (CEX2021-001165-S). ABT is a predoctoral fellow supported by Red de investigación en Atención Primaria de Adicciones (Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, grant number RD21/0009/0008 and RD24/0003/0002)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed